Literature DB >> 17376911

Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.

Mar Perez1, Roberto Clemente, Clinton S Robison, E Jeetendra, Himangi R Jayakar, Michael A Whitt, Juan C de la Torre.   

Abstract

Borna disease virus (BDV) is an enveloped virus with a nonsegmented negative-strand RNA genome whose organization is characteristic of mononegavirales. However, based on its unique genetics and biological features, BDV is considered to be the prototypic member of a new virus family, Bornaviridae, within the order Mononegavirales. BDV cell entry occurs via receptor-mediated endocytosis, a process initiated by the recognition of an as yet unidentified receptor at the cell surface by the BDV surface glycoprotein (G). The paucity of cell-free virus associated with BDV infection has hindered studies aimed at the elucidation of cellular receptors and detailed mechanisms involved in BDV cell entry. To overcome this problem, we generated and characterized a replication-competent recombinant vesicular stomatitis virus expressing BDV G (rVSVDeltaG*/BDVG). Cells infected with rVSVDeltaG*/BDVG produced high titers (10(7) PFU/ml) of cell-free virus progeny, but this virus exhibited a highly attenuated phenotype both in cell culture and in vivo. Attenuation of rVSVDeltaG*/BDVG was associated with a delayed kinetics of viral RNA replication and altered genome/N mRNA ratios compared to results for rVSVDeltaG*/VSVG. Likewise, incorporation of BDV G into virions appeared to be restricted despite its high levels of expression and efficient processing in rVSVDeltaG*/BDVG-infected cells. Notably, rVSVDeltaG*/BDVG recreated the cell tropism and entry pathway of bona fide BDV. Our results indicate that rVSVDeltaG*/BDVG represents a unique tool for the investigation of BDV G-mediated cell entry, as well as the roles of BDV G in host immune responses and pathogenesis associated with BDV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376911      PMCID: PMC1900261          DOI: 10.1128/JVI.02586-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.

Authors:  C S Robison; M A Whitt
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry.

Authors:  M Perez; M Watanabe; M A Whitt; J C de la Torre
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Identification of the amino terminal subunit of the glycoprotein of Borna disease virus.

Authors:  Simone Kiermayer; Ina Kraus; Jürgen A Richt; Wolfgang Garten; Markus Eickmann
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

4.  Open reading frame III of borna disease virus encodes a nonglycosylated matrix protein.

Authors:  I Kraus; M Eickmann; S Kiermayer; H Scheffczik; M Fluess; J A Richt; W Garten
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology.

Authors:  E Furrer; T Bilzer; L Stitz; O Planz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein.

Authors:  Roberto Clemente; Juan C de la Torre
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Matrix protein mutations contribute to inefficient induction of apoptosis leading to persistent infection of human neural cells by vesicular stomatitis virus.

Authors:  Marc Desforges; Geneviève Despars; Stéphane Bérard; Myriam Gosselin; Margie O McKenzie; Douglas S Lyles; Pierre J Talbot; Laurent Poliquin
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

Review 8.  Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders.

Authors:  Mikhail V Pletnikov; Timothy H Moran; Kathryn M Carbone
Journal:  Front Biosci       Date:  2002-03-01

9.  Neonatal Borna disease virus infection (BDV)-induced damage to the cerebellum is associated with sensorimotor deficits in developing Lewis rats.

Authors:  M V Pletnikov; S A Rubin; K M Carbone; T H Moran; G J Schwartz
Journal:  Brain Res Dev Brain Res       Date:  2001-01-31

10.  Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. I. Brain pathology and behavioral deficits.

Authors:  Mikhail V Pletnikov; Steven A Rubin; Michael W Vogel; Timothy H Moran; Kathryn M Carbone
Journal:  Brain Res       Date:  2002-07-19       Impact factor: 3.252

View more
  7 in total

1.  Involvement of ceramide in the propagation of Japanese encephalitis virus.

Authors:  Hideki Tani; Mai Shiokawa; Yuuki Kaname; Hiroto Kambara; Yoshio Mori; Takayuki Abe; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

2.  Cell entry of Borna disease virus follows a clathrin-mediated endocytosis pathway that requires Rab5 and microtubules.

Authors:  Roberto Clemente; Juan C de la Torre
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

3.  Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry.

Authors:  Roberto Clemente; Aymeric de Parseval; Mar Perez; Juan C de la Torre
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

4.  Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen.

Authors:  Roberto Clemente; Eugene Sisman; Pedro Aza-Blanc; Juan C de la Torre
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

5.  Cellular entry of lymphocytic choriomeningitis virus.

Authors:  Jillian M Rojek; Mar Perez; Stefan Kunz
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

6.  Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350.

Authors:  Hoyin Mok; Xing Cheng; Qi Xu; James R Zengel; Bandita Parhy; Jackie Zhao; C Kathy Wang; Hong Jin
Journal:  Open Virol J       Date:  2012-02-16

Review 7.  Recombinant vectors as influenza vaccines.

Authors:  Sarah A Kopecky-Bromberg; Peter Palese
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.